vs

Side-by-side financial comparison of DoubleVerify Holdings, Inc. (DV) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

DoubleVerify Holdings, Inc. is the larger business by last-quarter revenue ($205.6M vs $197.9M, roughly 1.0× REPLIGEN CORP). DoubleVerify Holdings, Inc. runs the higher net margin — 14.3% vs 6.7%, a 7.6% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 7.9%). DoubleVerify Holdings, Inc. produced more free cash flow last quarter ($62.1M vs $17.6M). Over the past eight quarters, DoubleVerify Holdings, Inc.'s revenue compounded faster (20.8% CAGR vs 14.4%).

Double Vision is a Malaysian production studio. Established in 1985, it has production hubs in Malaysia and Indonesia. Double Vision produces over 1,400 hours of television programming per year in various languages and genres for the regional market. It also houses international entertainment TV network, Channel [V], in its studios.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DV vs RGEN — Head-to-Head

Bigger by revenue
DV
DV
1.0× larger
DV
$205.6M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+5.8% gap
RGEN
13.6%
7.9%
DV
Higher net margin
DV
DV
7.6% more per $
DV
14.3%
6.7%
RGEN
More free cash flow
DV
DV
$44.6M more FCF
DV
$62.1M
$17.6M
RGEN
Faster 2-yr revenue CAGR
DV
DV
Annualised
DV
20.8%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DV
DV
RGEN
RGEN
Revenue
$205.6M
$197.9M
Net Profit
$29.3M
$13.3M
Gross Margin
82.5%
52.5%
Operating Margin
18.4%
9.0%
Net Margin
14.3%
6.7%
Revenue YoY
7.9%
13.6%
Net Profit YoY
25.3%
143.9%
EPS (diluted)
$0.18
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DV
DV
RGEN
RGEN
Q4 25
$205.6M
$197.9M
Q3 25
$188.6M
$188.8M
Q2 25
$189.0M
$182.4M
Q1 25
$165.1M
$169.2M
Q4 24
$190.6M
$174.1M
Q3 24
$169.6M
$154.9M
Q2 24
$155.9M
$154.1M
Q1 24
$140.8M
$151.3M
Net Profit
DV
DV
RGEN
RGEN
Q4 25
$29.3M
$13.3M
Q3 25
$10.2M
$14.9M
Q2 25
$8.8M
$14.9M
Q1 25
$2.4M
$5.8M
Q4 24
$23.4M
$-30.3M
Q3 24
$18.2M
$-654.0K
Q2 24
$7.5M
$3.3M
Q1 24
$7.2M
$2.1M
Gross Margin
DV
DV
RGEN
RGEN
Q4 25
82.5%
52.5%
Q3 25
82.3%
53.2%
Q2 25
82.5%
50.0%
Q1 25
81.2%
53.6%
Q4 24
82.0%
26.1%
Q3 24
82.6%
50.0%
Q2 24
83.3%
49.8%
Q1 24
81.1%
49.5%
Operating Margin
DV
DV
RGEN
RGEN
Q4 25
18.4%
9.0%
Q3 25
11.2%
8.9%
Q2 25
7.2%
7.6%
Q1 25
4.1%
3.9%
Q4 24
20.3%
-17.7%
Q3 24
15.2%
-5.1%
Q2 24
7.1%
1.0%
Q1 24
4.9%
1.3%
Net Margin
DV
DV
RGEN
RGEN
Q4 25
14.3%
6.7%
Q3 25
5.4%
7.9%
Q2 25
4.6%
8.2%
Q1 25
1.4%
3.4%
Q4 24
12.3%
-17.4%
Q3 24
10.7%
-0.4%
Q2 24
4.8%
2.2%
Q1 24
5.1%
1.4%
EPS (diluted)
DV
DV
RGEN
RGEN
Q4 25
$0.18
$0.24
Q3 25
$0.06
$0.26
Q2 25
$0.05
$0.26
Q1 25
$0.01
$0.10
Q4 24
$0.14
$-0.55
Q3 24
$0.10
$-0.01
Q2 24
$0.04
$0.06
Q1 24
$0.04
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DV
DV
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$259.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.1B
$2.1B
Total Assets
$1.4B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DV
DV
RGEN
RGEN
Q4 25
$259.0M
$767.6M
Q3 25
$200.7M
$748.7M
Q2 25
$216.8M
$708.9M
Q1 25
$174.3M
$697.2M
Q4 24
$310.6M
$757.4M
Q3 24
$362.6M
$784.0M
Q2 24
$338.8M
$809.1M
Q1 24
$334.3M
$780.6M
Total Debt
DV
DV
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DV
DV
RGEN
RGEN
Q4 25
$1.1B
$2.1B
Q3 25
$1.1B
$2.1B
Q2 25
$1.1B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$2.0B
Q2 24
$1.1B
$2.0B
Q1 24
$1.1B
$2.0B
Total Assets
DV
DV
RGEN
RGEN
Q4 25
$1.4B
$2.9B
Q3 25
$1.3B
$2.9B
Q2 25
$1.3B
$2.9B
Q1 25
$1.2B
$2.9B
Q4 24
$1.3B
$2.8B
Q3 24
$1.3B
$2.8B
Q2 24
$1.3B
$2.9B
Q1 24
$1.3B
$2.8B
Debt / Equity
DV
DV
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DV
DV
RGEN
RGEN
Operating Cash FlowLast quarter
$72.7M
$25.7M
Free Cash FlowOCF − Capex
$62.1M
$17.6M
FCF MarginFCF / Revenue
30.2%
8.9%
Capex IntensityCapex / Revenue
5.1%
4.1%
Cash ConversionOCF / Net Profit
2.48×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$172.7M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DV
DV
RGEN
RGEN
Q4 25
$72.7M
$25.7M
Q3 25
$51.2M
$48.1M
Q2 25
$49.6M
$28.6M
Q1 25
$37.7M
$15.0M
Q4 24
$37.4M
$39.2M
Q3 24
$54.6M
$49.3M
Q2 24
$35.9M
$42.2M
Q1 24
$31.8M
$44.7M
Free Cash Flow
DV
DV
RGEN
RGEN
Q4 25
$62.1M
$17.6M
Q3 25
$39.0M
$43.4M
Q2 25
$40.1M
$21.5M
Q1 25
$31.4M
$11.4M
Q4 24
$30.0M
$33.6M
Q3 24
$48.4M
$42.3M
Q2 24
$28.7M
$37.4M
Q1 24
$25.4M
$36.4M
FCF Margin
DV
DV
RGEN
RGEN
Q4 25
30.2%
8.9%
Q3 25
20.7%
23.0%
Q2 25
21.2%
11.8%
Q1 25
19.0%
6.8%
Q4 24
15.8%
19.3%
Q3 24
28.5%
27.3%
Q2 24
18.4%
24.3%
Q1 24
18.0%
24.0%
Capex Intensity
DV
DV
RGEN
RGEN
Q4 25
5.1%
4.1%
Q3 25
6.4%
2.5%
Q2 25
5.0%
3.9%
Q1 25
3.8%
2.1%
Q4 24
3.9%
3.2%
Q3 24
3.7%
4.5%
Q2 24
4.6%
3.1%
Q1 24
4.5%
5.5%
Cash Conversion
DV
DV
RGEN
RGEN
Q4 25
2.48×
1.93×
Q3 25
5.02×
3.23×
Q2 25
5.66×
1.92×
Q1 25
15.95×
2.57×
Q4 24
1.60×
Q3 24
3.00×
Q2 24
4.80×
12.70×
Q1 24
4.44×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DV
DV

Activation$116.5M57%
Measurement$69.6M34%
Supply Side$19.5M9%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons